liu.seSearch for publications in DiVA
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • oxford
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Impact of conflicting information on the use of antirheumatic drugs in pregnancy and breastfeeding: perspectives of healthcare providers from the global PRAISE survey
Danish Hosp Rheumat Dis, Denmark; Southern Danish Univ, Denmark; Guys & St Thomas NHS Fdn Trust, England.
Danish Hosp Rheumat Dis, Denmark; Aarhus Univ Hosp, Denmark.
Karolinska Inst, Sweden; Karolinska Univ Hosp, Sweden; Örebro Univ, Sweden.
Sheba Med Ctr, Israel.
Show others and affiliations
2025 (English)In: Therapeutic Advances in Musculoskeletal Disease, ISSN 1759-7218, E-ISSN 1759-720X, Vol. 17, article id 1759720X251350087Article in journal (Refereed) Published
Abstract [en]

Background: Treating rheumatic musculoskeletal diseases (RMDs) during pregnancy and breastfeeding presents significant complexities, mainly due to inconsistencies between the clinical guidance documents and the reference safety information, including the summary of product characteristics (SmPC) and the patient information leaflets (PIL).Objectives: To assess healthcare professionals' (HCPs) prescribing behaviors, comfort levels, and challenges when advising patients, focusing on discrepancies between clinical guidance documents and SmPC/PIL.Design: Online survey entitled PRAISE (Perception of healthcare providers Regarding Antirheumatics in pregnancy and breastfeeding: advice, Information and patient perSpEctives) and disseminated through HCPs groups and social media.Methods: A cross-sectional survey was conducted among 414 HCPs globally. Respondents were divided into prescribers (n = 336) and non-prescribers (n = 78) based on their self-reported role in prescribing antirheumatic medications to pregnant or breastfeeding patients with RMDs. The survey covered demographics, clinical experience, confidence in prescribing, use of clinical guidelines, and experiences managing conflicting information between guidelines and SmPC/PIL.Results: Prescribers were more likely than non-prescribers to feel comfortable discussing medication safety during pregnancy. Most prescribers found clinical guidance documents useful, with 48% rating them as "very useful" and 38% as "extremely useful." In case of conflicting information between clinical guidance documents and SmPC/PIL, 58% of HCPs reported that it caused confusion and tension in patient-doctor relationships, and almost 20% of them are "likely" or "very likely" to discontinue ongoing treatment. Clear communication and shared decision-making were the most common strategies used to address patient concerns.Conclusion: HCPs often face significant challenges when advising patients with RMDs on the use of medications during pregnancy and breastfeeding. Conflicting information between clinical guidance documents and SmPC/PIL can disrupt patient-doctor relationship and lead to treatment discontinuation, with potential consequences on maternal disease control. Improved alignment between clinical guidance documents and the SmPC/PIL could enhance patient care and prevent confusion among HCPs and patients.

Place, publisher, year, edition, pages
SAGE PUBLICATIONS LTD , 2025. Vol. 17, article id 1759720X251350087
Keywords [en]
antirheumatic medications; breastfeeding; lactation; patient information leaflet; pregnancy; summary of product characteristics
National Category
Social and Clinical Pharmacy
Identifiers
URN: urn:nbn:se:liu:diva-216921DOI: 10.1177/1759720X251350087ISI: 001529720900001PubMedID: 40678818OAI: oai:DiVA.org:liu-216921DiVA, id: diva2:1992694
Note

Funding Agencies|Study Group on Reproductive Health and Family Planning; Centre of Expertise in Rheumatology

Available from: 2025-08-28 Created: 2025-08-28 Last updated: 2025-10-07

Open Access in DiVA

fulltext(1819 kB)97 downloads
File information
File name FULLTEXT01.pdfFile size 1819 kBChecksum SHA-512
ca1e77778c0b5831986ecaf5ea1b86e8d60cdb0552f90b2a147057894429b92819146d9aa140139060b98b05d50c42a7a422e69d8223883ef82011b59682e0bb
Type fulltextMimetype application/pdf

Other links

Publisher's full textPubMed

Search in DiVA

By author/editor
Saleh, Muna Atallah
By organisation
Division of Inflammation and InfectionFaculty of Medicine and Health SciencesDepartment of Rheumatology
In the same journal
Therapeutic Advances in Musculoskeletal Disease
Social and Clinical Pharmacy

Search outside of DiVA

GoogleGoogle Scholar
Total: 97 downloads
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

doi
pubmed
urn-nbn

Altmetric score

doi
pubmed
urn-nbn
Total: 39 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • oxford
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf